CAS 1474110-21-8
:Formel:C25H35NO5S
InChl:InChI=1S/C25H35NO5S/c1-4-20-5-7-23(8-6-20)26(16-19(2)3)32(28,29)24-9-10-25(22(15-24)17-27)31-18-21-11-13-30-14-12-21/h5-10,15,19,21,27H,4,11-14,16-18H2,1-3H3
InChI Key:LZLBRISQTJVZNP-UHFFFAOYSA-N
SMILES:CCC1=CC=C(C=C1)N(CC(C)C)S(=O)(=O)C2=CC(=C(C=C2)OCC3CCOCC3)CO
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte gefunden.
N-(4-Ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide
CAS:Formel:C25H35NO5SReinheit:%Farbe und Form:SolidMolekulargewicht:461.6141N-(4-Ethylphenyl)-3-(Hydroxymethyl)-N-Isobutyl-4-((Tetrahydro-2H-Pyran-4-Yl)Methoxy)Benzenesulfonamide
CAS:N-(4-Ethylphenyl)-3-(Hydroxymethyl)-N-Isobutyl-4-((Tetrahydro-2H-Pyran-4-Yl)Methoxy)BenzenesulfonamideFormel:C25H35NO5SReinheit:98+%Molekulargewicht:461.61GSK2981278
CAS:GSK2981278 (ROR gama modulator 1) is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan receptor gamma (ROR gamma).Formel:C25H35NO5SReinheit:99.31% - 99.67%Farbe und Form:SolidMolekulargewicht:461.61GSK2981278
CAS:N-(4-Ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamideFormel:C25H35NO5SReinheit:98+%Molekulargewicht:461.61GSK2981278
CAS:GSK2981278 is a novel investigational product developed by GlaxoSmithKline. It is a potent and selective activator of the transcription factor Nrf2, derived through advanced medicinal chemistry and designed for targeted pharmacological effects. This compound functions by modulating the Nrf2 pathway, which plays a pivotal role in the cellular response to oxidative stress. By activating Nrf2, GSK2981278 aims to enhance the cellular defense systems, thereby mitigating oxidative damage.Formel:C25H35NO5SReinheit:Min. 95%Molekulargewicht:461.61 g/mol
